R P Hertzberg
Affiliation: SmithKline Beecham Pharmaceuticals
- High-throughput screening: new technology for the 21st centuryR P Hertzberg
Molecular Screening Technologies, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA
Curr Opin Chem Biol 4:445-51. 2000..Furthermore, new technologies are now being applied to information-rich cell-based assays, and this is beginning to remove one of the key bottlenecks downstream from primary screening...